| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $33.7M | +73.9% |
| SG&A Expense | $9.3M | +13.3% |
| Operating Income | -$43.0M | -56.0% |
| Pre-tax Income | -$13.3M | +77.5% |
| Income Tax | $0 | — |
| Net Income | -$15.3M | +75.5% |
| EPS (Basic) | -$0.19 | +81.4% |
| EPS (Diluted) | -$0.53 | +48.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -47.6% |
| Accounts Receivable | $37K | -50.7% |
| Current Assets | $58.2M | +7.0% |
| Total Assets | $71.1M | +3.2% |
| Current Liabilities | $9.4M | -73.5% |
| Total Liabilities | $9.9M | -72.7% |
| Stockholders' Equity | $61.2M | +87.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.8M | -29.0% |
| Capital Expenditures | $174K | — |
| Investing Cash Flow | -$7.8M | +71.6% |
| Financing Cash Flow | $36.4M | -25.7% |
| Free Cash Flow | -$33.0M | — |